Poonawalla Management Consultancy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 48.31%
(FY 2022)
- Profit -64.03%
(FY 2022)
- Ebitda -64.96%
(FY 2022)
- Net Worth 28.00%
(FY 2022)
- Total Assets 67.99%
(FY 2022)
About Poonawalla Management Consultancy
The Corporate was formerly known as Greenkalpa Pharma Private Limited. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Purushottam Adep and Dattatraya Dhavalikar serve as directors at the Company.
- CIN/LLPIN
U74110PN2018PTC178728
- Company No.
178728
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Poonawalla Management Consultancy?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purushottam Adep  | Director | 17-Sep-2018 | Current |
| Dattatraya Dhavalikar | Director | 17-Sep-2018 | Current |
Financial Performance of Poonawalla Management Consultancy.
Poonawalla Management Consultancy Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.31% increase. The company also saw a substantial fall in profitability, with a 64.03% decrease in profit. The company's net worth Soared by an impressive increase of 28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Poonawalla Management Consultancy?
In 2022, Poonawalla Management Consultancy had a promoter holding of 0.20% and a public holding of 99.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yogavid Biotech Private LimitedActive 7 years 4 monthsPurushottam Adep and Dattatraya Dhavalikar are mutual person
- Jeevadravya Bio-Pharma Private LimitedActive 6 years 3 months
Dattatraya Dhavalikar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Poonawalla Management Consultancy?
Unlock and access historical data on people associated with Poonawalla Management Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Poonawalla Management Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Poonawalla Management Consultancy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
